Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-05 Sale | 2024-02-07 8:32 pm | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 24,552 | $30.05 | $737,788 | 257,043 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A 2030-11-08 | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 24,000 | $0 | 257,043 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 6,000 | $15.78 | 257,043 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 6,000 | $8.04 | 257,043 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 8:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 12,000 | $18.66 | 257,043 (Direct) | View |
Ownership(A) | 2024-02-07 7:42 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 0 | $0 | 1,595 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2023-04-05 9:28 pm | N/A 2030-11-08 | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 0 | $0 | 320,000 (Direct) | View |